Rocephin



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 36.0%
Product Used For Unknown Indication 18.0%
Pneumonia 9.8%
Bronchitis 4.5%
Pyrexia 4.3%
Infection 3.9%
Urinary Tract Infection 3.7%
Pyelonephritis 3.3%
Sepsis 2.5%
Prophylaxis 2.2%
Meningitis 1.7%
Tonsillitis 1.3%
Lung Infection 1.2%
Meningitis Bacterial 1.1%
Pain 1.1%
Bronchopneumonia 1.1%
Hypertension 1.1%
Bronchopneumopathy 1.1%
Pneumonia Mycoplasmal 1.0%
Bacterial Infection 1.0%
Renal Failure Acute 10.2%
Rash 7.3%
Urticaria 7.3%
Toxic Epidermal Necrolysis 6.8%
Thrombocytopenia 6.2%
Anaphylactic Shock 6.0%
Cholelithiasis 6.0%
Stevens-johnson Syndrome 5.9%
Vomiting 5.0%
Pyrexia 4.7%
Shock 4.5%
Pancytopenia 4.3%
Death 4.0%
Liver Disorder 3.4%
Pancreatitis 3.4%
Renal Failure 3.3%
Cytolytic Hepatitis 2.9%
Dyspnoea 2.9%
Hepatic Function Abnormal 2.9%
Acute Generalised Exanthematous Pustulosis 2.8%
Secondary
Product Used For Unknown Indication 28.9%
Drug Use For Unknown Indication 16.8%
Pneumonia 7.0%
Hypertension 6.4%
Pyrexia 5.1%
Unevaluable Event 3.6%
Urinary Tract Infection 3.3%
Ill-defined Disorder 3.2%
Lung Disorder 2.7%
Prophylaxis 2.6%
Infection 2.5%
Lung Infection 2.3%
Pain 2.3%
Sepsis 2.2%
Bronchitis 2.2%
Tonsillitis 2.0%
Endocarditis 2.0%
Bacterial Infection 1.8%
Sedation 1.6%
Chronic Obstructive Pulmonary Disease 1.5%
Thrombocytopenia 11.1%
Toxic Epidermal Necrolysis 9.4%
Drug Rash With Eosinophilia And Systemic Symptoms 8.1%
Renal Failure Acute 8.1%
Toxic Skin Eruption 6.8%
Pyrexia 5.8%
Stevens-johnson Syndrome 5.8%
Urticaria 5.8%
Vomiting 4.5%
Anaphylactic Shock 4.1%
Rash 4.1%
White Blood Cell Count Increased 4.1%
Drug Hypersensitivity 3.4%
Neutropenia 3.2%
Renal Failure 3.0%
Rhabdomyolysis 2.8%
Erythema Multiforme 2.6%
Cytolytic Hepatitis 2.4%
Septic Shock 2.4%
Liver Disorder 2.3%
Concomitant
Product Used For Unknown Indication 25.4%
Drug Use For Unknown Indication 18.9%
Prophylaxis 6.5%
Pain 6.2%
Hypertension 5.4%
Pneumonia 5.3%
Multiple Myeloma 4.1%
Infection 3.3%
Pyrexia 2.9%
Nausea 2.5%
Constipation 2.4%
Urinary Tract Infection 2.3%
Depression 2.3%
Sepsis 2.2%
Insomnia 2.0%
Breast Cancer 1.9%
Asthma 1.8%
Anxiety 1.7%
Osteoporosis 1.5%
Bronchitis 1.5%
Vomiting 10.6%
Weight Decreased 8.6%
Thrombocytopenia 7.9%
Pyrexia 6.5%
Pulmonary Embolism 6.3%
Urinary Tract Infection 6.2%
Renal Failure Acute 5.9%
White Blood Cell Count Increased 5.7%
Pneumonia 5.0%
Sepsis 4.2%
White Blood Cell Count Decreased 4.0%
Wound Infection Staphylococcal 3.6%
Varicella 3.5%
Rhabdomyolysis 3.4%
Wheezing 3.4%
Weight Increased 3.3%
Suicide Attempt 3.2%
Neutropenia 3.1%
Pain 2.8%
Rash 2.8%
Interacting
Hypertension 19.8%
Drug Use For Unknown Indication 12.8%
Product Used For Unknown Indication 11.4%
Pneumonia 7.4%
Chronic Obstructive Pulmonary Disease 6.4%
Urinary Tract Infection 5.4%
Helicobacter Infection 4.0%
Pneumonia Bacterial 3.4%
Psoriatic Arthropathy 3.4%
Depression 3.0%
Lung Disorder 2.7%
Pain 2.7%
Type 1 Diabetes Mellitus 2.7%
Coronary Artery Disease 2.3%
Hyperlipidaemia 2.3%
Prophylaxis Against Gastrointestinal Ulcer 2.3%
Atrial Fibrillation 2.0%
Localised Infection 2.0%
Respiratory Tract Infection 2.0%
Unevaluable Event 2.0%
Drug Interaction 29.3%
International Normalised Ratio Increased 7.3%
Respiratory Failure 7.3%
Clostridium Difficile Colitis 4.9%
Enterocolitis 4.9%
Gastrointestinal Inflammation 4.9%
Hypokalaemia 4.9%
Renal Failure Acute 4.9%
Somnolence 4.9%
Abdominal Wall Haematoma 2.4%
Anxiety 2.4%
Cytomegalovirus Test Positive 2.4%
Enterocolitis Haemorrhagic 2.4%
Haematoma 2.4%
Haemorrhoids 2.4%
Proteus Infection 2.4%
Pyrexia 2.4%
Respiratory Acidosis 2.4%
Rhabdomyolysis 2.4%
Staphylococcal Infection 2.4%